Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Julphar
Mallinckrodt
Johnson and Johnson
Queensland Health
Express Scripts
Chubb
Deloitte
Chinese Patent Office

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021192

« Back to Dashboard

NDA 021192 describes LESCOL XL, which is a drug marketed by Novartis and is included in one NDA. It is available from four suppliers. There is one patent protecting this drug and one Paragraph IV challenge. Additional details are available on the LESCOL XL profile page.

The generic ingredient in LESCOL XL is fluvastatin sodium. There are eleven drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the fluvastatin sodium profile page.
Summary for 021192
Tradename:LESCOL XL
Applicant:Novartis
Ingredient:fluvastatin sodium
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 021192
Suppliers and Packaging for NDA: 021192
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
LESCOL XL fluvastatin sodium TABLET, EXTENDED RELEASE;ORAL 021192 NDA Novartis Pharmaceuticals Corporation 0078-0354 N 0078-0354-05
LESCOL XL fluvastatin sodium TABLET, EXTENDED RELEASE;ORAL 021192 NDA Novartis Pharmaceuticals Corporation 0078-0354 N 0078-0354-15

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 80MG BASE
Approval Date:Oct 6, 2000TE:ABRLD:Yes
Patent:➤ Try a Free TrialPatent Expiration:Oct 13, 2020Product Flag?Substance Flag?Delist Request?Y

Expired US Patents for NDA 021192

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Novartis LESCOL XL fluvastatin sodium TABLET, EXTENDED RELEASE;ORAL 021192-001 Oct 6, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Novartis LESCOL XL fluvastatin sodium TABLET, EXTENDED RELEASE;ORAL 021192-001 Oct 6, 2000 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Johnson and Johnson
Harvard Business School
Covington
Citi
Argus Health
Boehringer Ingelheim
Healthtrust
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.